NCT02372383View on ClinicalTrials.gov

Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cystic Fibrosis
Interventions
DRUG

Ethambutol

Anti-mycobacterial oral drug

DRUG

Rifampin

Anti-mycobacterial oral drug

DRUG

Azithromycin

Anti-mycobacterial oral drug

DRUG

Pancrelipase

Pancreatic enzyme replacement therapy

Trial Locations (1)

80045

Children's Hospital Colroado, Aurora

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

Colorado Clinical & Translational Sciences Institute

OTHER

lead

University of Colorado, Denver

OTHER

NCT02372383 - Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis | Biotech Hunter | Biotech Hunter